This is Part 3 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 2). Big Data — the vast amount...

Incretins are hormones that the body uses to stimulate insulin release when nutrients are ingested. The two that are the most well-studied are...

This is Part 2 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 3). Recent medical technology...

So how does the pharmaceutical industry restore its jaded public image? The answer is by changing itself from within, by paying more than just lip...

This is Part 1 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 2 and Part 3). Medical research and...

The San Diego Business Journal announced today that Scientist CEO, Dr. Kevin Lustig, was awarded the Most Admired CEO for a small privately held...

At Scientist, we discuss the latest trends in drug development, techniques, and the pharmaceutical industry. Here are the top posts from 2013. 10...

The need for CNS therapeutics is on the rise. Neurological diseases are expected to increase steadily in the coming years. Previously, we addressed...

More than $2 trillion dollars a year are spent on treatments for CNS disorders. One in three people over 80 currently has Alzheimer’s disease. With...